On September 8, 2022 Sitryx Therapeutics Ltd (the "Company"), a biopharmaceutical company pioneering the field of immunometabolism, reported that the Company will participate virtually in the following events (Press release, Sitryx, SEP 8, 2022, View Source [SID1234619293]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

UBS Biotechnology Private Company Symposium, Sept. 21-22, 2022
Neil Weir, Chief Executive Officer of Sitryx, will present a company overview on September 21st at 9am ET
Company management will conduct virtual one-on-one meetings with investors during the conference

Longwood Healthcare Leaders Fall Webconference, Sept. 22, 2022
Neil Weir, Chief Executive Officer of Sitryx, will participate in a panel discussion titled "Moving from Data to Medicine"
To learn more about the Longwood event, view the agenda, and request an invitation, visit www.longwoodhealthcareleaders.com. To request an invitation or recommend a colleague, please email [email protected].

Needham Private Biotech Company Virtual 1×1 Forum, Oct. 18-19, 2022
Company management will conduct virtual one-on-one meetings with investors during the conference